Enhanced State Opioid Overdose Surveillance (ESOOS) Program Overview

These slides were presented at the Enhanced State Opioid Overdose Surveillance (ESOOS) Program Overview Partner meeting, led by CDC and organized by ASTHO in March of 2019. 

Presenters

Puja Seth, PhD – Lead, Epidemiology and Surveillance

Alana Vivolo-Kantor, PhD – Morbidity Lead

Christine L. Mattson, PhD – Mortality Lead

Objectives

March 27, 2019

Comparing Syndromic Data to Discharge Data to Measure Opioid Overdose Emergency Department Visits

Timely and accurate measurement of overdose morbidity using emergency department (ED) data is necessary to inform an effective public health response given the dynamic nature of opioid overdose epidemic in the United States. However, from jurisdiction to jurisdiction, differing sources and types of ED data vary in their quality and comprehensiveness. Many jurisdictions collect timely emergency department data through syndromic surveillance (SyS) systems, while others may have access to more complete, but slower emergency department discharge datasets.

June 18, 2019

Monitoring suicide-related events using National Syndromic Surveillance Program data

Suicide is a growing public health problem in the United States. From 2001 to 2016, ED visit rates for nonfatal self-harm, a common risk factor for suicide, increased 42%.

June 18, 2019

Syndrome definitions for drug overdose: How far down the rabbit hole do we go?

State and local jurisdictions have been exploring the use of SyS data to monitor suspected drug overdose outbreaks in their communities. With the increasing awareness and use of SyS systems, staff from the Centers for Disease Control and Prevention (CDC) worked to develop several queries that jurisdictions could use to better capture suspected drug overdose visits. In 2017, CDC released their first two queries on heroin overdose and opioid overdose, followed in 2018 by stimulant and all drug overdose queries.

June 18, 2019

Trends in Suspected Opioid Overdoses from Emergency Departments in 11 States and DC

Recent reporting using data from CDC's National Syndromic Surveillance Program indicates that rates of emergency department (ED) visits involving suspected opioid overdoses increased by 70% in the Midwest from the third quarter (Q3) 2016 (July-September) to the Q3 2017. Large increases in the use and distribution of illicitly-manufactured fentanyl (IMF) and fentanyl analogs, are a key factor driving increased opioid overdose rates in the Midwest and east of the Mississippi River. Fentanyl is a synthetic opioid 50-“100 times more potent than morphine.

June 18, 2019

Tracking suspected heroin overdoses in CDC's National Syndromic Surveillance Program

Overdose deaths involving opioids (i.e., opioid pain relievers and illicit opioids such as heroin) accounted for at least 63% (N = 33,091) of overdose deaths in 2015. Overdose deaths related to illicit opioids, heroin and illicitly-manufactured fentanyl, have rapidly increased since 2010. For instance, heroin overdose deaths quadrupled from 3,036 in 2010 to 12,989 in 2015. Unfortunately, timely response to emerging trends is inhibited by time lags for national data on both overdose mortality via vital statistics (8-12 months) and morbidity via hospital discharge data (over 2 years).

January 21, 2018

CDC Stimulant v2

THE KNOWLEDGE REPOSITORY HAS BEEN UPDATED TO INCLUDE CDC STIMULANT OVERDOSE V3 - THE UPDATED SYNDROME DEFINITION CAN BE FOUND HERE.

August 29, 2018

CDC Heroin v3

THE KNOWLEDGE REPOSITORY HAS BEEN UPDATED TO INCLUDE CDC HEROIN OVERDOSE V4 - THE UPDATED SYNDROME DEFINITION CAN BE FOUND HERE.

August 29, 2018

CDC Opioid v2

THE KNOWLEDGE REPOSITORY HAS BEEN UPDATED TO INCLUDE CDC OPIOID V3 - THE UPDATED SYNDROME DEFINITION CAN BE FOUND HERE.

August 29, 2018

CDC All Drug v1

THE KNOWLEDGE REPOSITORY HAS BEEN UPDATED TO INCLUDE CDC ALL DRUG V2 - THE UPDATED SYNDROME DEFINITION CAN BE FOUND HERE.

October 11, 2018

Pages

Contact Us

NSSP Community of Practice

Email: syndromic@cste.org

 

This website is supported by Cooperative Agreement # 6NU38OT000297-02-01 Strengthening Public Health Systems and Services through National Partnerships to Improve and Protect the Nation's Health between the Centers for Disease Control and Prevention (CDC) and the Council of State and Territorial Epidemiologists. Its contents are solely the responsibility of the authors and do not necessarily represent the official views of CDC. CDC is not responsible for Section 508 compliance (accessibility) on private websites.

Site created by Fusani Applications